Newsletter

Undervalued Stocks

Turners Automotive (ASX:TRA): A Great 5-Year Track Record, But Will The Run Continue?

If you want a lesson in how a New Zealand company can quietly and consistently build shareholder wealth, look no further than Turners Automotive (ASX:TRA). On Tuesday March 24, the group held its 2026 Investor Day in Auckland and what was on show was not just a company that has executed well. It was a company…

ByNick SundichMarch 25, 2026

The Impact of The Iran War Extends Beyond Oil, And this ASX Company is the Poster Child for It!

It is easy to think the Impact of The Iran War is simply businesses in the oil space or that use oil in their operations (for instance freight businesses). Or by extension, companies in the 'consumer discretionary' space that find due to higher energy prices (and interest rates), that their goods are more discretionary than…

ByNick SundichMarch 25, 2026

Synlait (ASX:SM1): You Can’t Fault Management’s Honesty, But Can You Have Hope?

There is a particular kind of corporate announcement that arrives not with spin, but with a kind of exhausted candour, and we saw just this when Synlait issued its 1H26 result yesterday. "We are not going to attempt to dress things up," wrote Chair George Adams and CEO Richard Wyeth in their joint letter to shareholders…

ByNick SundichMarch 24, 2026

Core Lithium’s Finniss Lithium Project Is Go! And Glencore is Helping With the Restart!

An FID (Final Investment Decision) has been made on Core Lithium's (ASX:CXO) Finniss Lithium Project. With this news, and the securing of a US$120m/A$170m funding package, it is a great day to be a Core Lithium shareholder. What are the Best ASX stocks to invest in right now? Check our buy/sell tips [sg_popup id="23914" event="click"][/sg_popup] Recap of Core…

ByNick SundichMarch 18, 2026

The Looming Demotion: Here’s Why These 8 ASX Stocks Are Being Removed from the ASX All Ords!

In a couple of weeks, some ASX Stocks Are Being Removed from the ASX All Ords. Other companies will take their place and it was only yesterday that we wrote about that fact and some of the companies being promoted. But today it is time to look at the stocks suffering the indignity of being…

ByNick SundichMarch 13, 2026

ASX All Ordinaries Stocks: Here’s Why These 8 Companies Joined the Club In the Latest Rebalance!

Twice a year, specifically on the third Fridays of March and September, the list of ASX All Ordinaries Stocks changes as stocks are added and demoted. Their promotions and demotions happen for various reasons that all feed into an increase or decrease in the company's market capitalisation. In this article, we look at 8 companies that…

ByNick SundichMarch 12, 2026

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

In all our years, we have seen our fair share of ASX Company Spin. It is repeated because often investors fall for it. Even if not all do, it is sufficient that some investors fall for it to achieve what has to be achieved. For instance, that enough believe a capital raising at a >25% discount…

ByNick SundichFebruary 19, 2026

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

Investors may remember Rhythm Biosciences (ASX:RHY) for its ColoSTAT test, but it is Genetype that is arguably more exciting. The company now has a substantially larger market awaiting us, and while its commercialisation strategy for ColoSTAT has changed, this strategy has been successful. Wait, has Rhythm received TGA approval? Yes and no - it's a long…

ByNick SundichFebruary 17, 2026

Compumedics (ASX:CMP): Expecting $70m sales but trading at barely over 1x Revenues, is this a buy?

Some investors may think Compumedics (ASX:CMP) is highly undervalued. It trades at $75m, a level that many clinical-stage medtech or biotech stocks are trading well above...but Compumedics is a commercial-stage company expecting nearly that amount of sales for an entire year. What's the story here? What are the Best ASX stocks to invest in right now? Check…

ByNick SundichJanuary 27, 2026

Stocks Down Under’s Top 10 Hottest ASX Stocks to Look At in 2026!

Today, on the first trading day of 2026, Stocks Down Under publishes its its 10 Hottest ASX Stocks to Look At in the year ahead! What are the Best ASX Stocks to invest in right now? Check our buy/sell tips [sg_popup id="23914" event="click"][/sg_popup] Stocks Down Under's Top 10 Hottest ASX Stocks to Look At in 2026! Note: These…

ByNick SundichJanuary 2, 2026

the Kick-ass Multipurpose WordPress Theme

Undervalued Stocks

Turners Automotive (ASX:TRA): A Great 5-Year Track Record, But Will The Run Continue?

The Impact of The Iran War Extends Beyond Oil, And this ASX Company is the Poster Child for It!

Synlait (ASX:SM1): You Can’t Fault Management’s Honesty, But Can You Have Hope?

Core Lithium’s Finniss Lithium Project Is Go! And Glencore is Helping With the Restart!

The Looming Demotion: Here’s Why These 8 ASX Stocks Are Being Removed from the ASX All Ords!

ASX All Ordinaries Stocks: Here’s Why These 8 Companies Joined the Club In the Latest Rebalance!

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

Compumedics (ASX:CMP): Expecting $70m sales but trading at barely over 1x Revenues, is this a buy?

Stocks Down Under’s Top 10 Hottest ASX Stocks to Look At in 2026!

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Undervalued Stocks

Stocks in Spotlight

Add Your Heading Text Here